A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...
All nine macaques given the control developed severe disease when exposed to bird flu, as did all given the smallest dose of ...
Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The H5N1 virus has raised concern among health officials because ... “The project will provide additional support for ...
Researchers at Texas Biomed have identified nine mutations in a strain of bird flu found in a person in Texas. Bad news: This ...
The US Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS) today confirmed more H5N1 avian ...
Sec. Mike Naig says the U.S. government is using what he describes as a three-legged stool approach to address the virus in ...
"This type of prevention can be very useful in controlling infection outbreaks and containing the bird flu pandemic," said an immunologist.
The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.
A California duck farm has culled thousands of birds as the virus seems to be trading genetics with other viruses ...